152 related articles for article (PubMed ID: 3079026)
1. Skin test reactivity and lymphocyte subsets in cyclosporine versus azathioprine-treated renal transplant recipients.
Pomer S; Daniel V; Dreikorn K; Röhl L
Transplant Proc; 1987 Feb; 19(1 Pt 2):1568-9. PubMed ID: 3079026
[No Abstract] [Full Text] [Related]
2. Identification and function of a major OKT3, OKT8, Leu-7, positive lymphocyte subpopulation in renal transplant recipients treated with total lymphoid irradiation.
Waer M; Vanrenterghem Y; Van der Schueren E; Michielsen P; Vandeputte M
Transplant Proc; 1987 Feb; 19(1 Pt 2):1570-1. PubMed ID: 3079027
[No Abstract] [Full Text] [Related]
3. Conversion from azathioprine and/or prednisolone to cyclosporine A in renal allograft recipients.
Ebel H; Lange H
Transplant Proc; 1987 Feb; 19(1 Pt 3):2005-6. PubMed ID: 3274463
[No Abstract] [Full Text] [Related]
4. A prospective study on the influence of cyclosporine and azathioprine on renal allograft survival and function.
Henny FC; Kootte AM; van Bockel JH; Baldwin WM; Hermans J; Bos B; van Es LA; Paul LC
Transplant Proc; 1987 Feb; 19(1 Pt 3):1853-5. PubMed ID: 3079050
[No Abstract] [Full Text] [Related]
5. Immunosuppression with cyclosporine, azathioprine, and prednisolone in cadaver renal allograft recipients.
Jones RM; Murie JA; Allen R; Jaskowski A; Morris PJ
Transplant Proc; 1987 Feb; 19(1 Pt 3):1926. PubMed ID: 3274453
[No Abstract] [Full Text] [Related]
6. Histological changes in renal allografts after successful conversion from cyclosporin A to azathioprine.
Junor BJ; More IA; Bradley JA; Briggs JD; Kyle KF; McGregor E; McMillan MA; Macpherson SG; Van der Merwe W; Rodger RS
Transplant Proc; 1989 Feb; 21(1 Pt 2):1677-9. PubMed ID: 2652549
[No Abstract] [Full Text] [Related]
7. A controlled trial of triple therapy in renal transplantation.
Salaman JR; Griffin PJ; Ross WB; Williams JD
Transplant Proc; 1987 Feb; 19(1 Pt 3):1935-6. PubMed ID: 3079061
[No Abstract] [Full Text] [Related]
8. A comparison of triple therapy with double therapy (cyclosporine/azathioprine) in low-risk, first cadaveric renal allograft recipients.
Restifo AC; Petrie JJ; Rigby RJ; Hardie IR; Jacob CK; Russ GR; Mathew TH
Transplant Proc; 1989 Feb; 21(1 Pt 2):1604-5. PubMed ID: 2652522
[No Abstract] [Full Text] [Related]
9. Elective conversion from cyclosporine to azathioprine and prednisolone in patients after cadaveric renal transplantation: observations on graft survival and renal function.
Tegzess AM; van Son WJ; de Maar EF; Beelen JM; Sluiter WJ; Huisman RM
Transplant Proc; 1989 Feb; 21(1 Pt 2):1635-7. PubMed ID: 2652534
[No Abstract] [Full Text] [Related]
10. The mechanism of hyperuricaemia in cyclosporine-treated renal transplant recipients.
Cohen SL; Boner G; Rosenfeld JB; Shmueli D; Sperling O; Yusim A; Todd-Pokropek A; Shapira Z
Transplant Proc; 1987 Feb; 19(1 Pt 2):1829-30. PubMed ID: 3079042
[No Abstract] [Full Text] [Related]
11. Discontinuation of one drug in triple drug treatment of renal allograft patients: 1-year results.
Isoniemi H; Eklund B; Höckerstedt K; Korsbäck C; Salmela K; von Willebrand E; Häyry P; Ahonen J
Transplant Proc; 1990 Aug; 22(4):1365-6. PubMed ID: 2202111
[No Abstract] [Full Text] [Related]
12. Morphological and functional findings in renal transplant recipients on cyclosporine and azathioprine treatment.
Backman U; Bohman SO; Johansson G; Lindgren PG; Wahlberg J
Transplant Proc; 1987 Feb; 19(1 Pt 2):1639-40. PubMed ID: 3079029
[No Abstract] [Full Text] [Related]
13. Low-dose cyclosporine or azathioprine one year after renal transplantation.
Forwell MA; Bradley JA; Briggs JD; Brown MW; Junor BJ; Macpherson SG; Watson MA
Transplant Proc; 1987 Feb; 19(1 Pt 3):1858-9. PubMed ID: 3079052
[No Abstract] [Full Text] [Related]
14. Triple combination of low-dose cyclosporine, azathioprine, and steroids in first cadaver donor renal allografts.
Fries D; Hiesse C; Charpentier B; Rieu P; Neyrat N; Cantarovich M; Ouziala M; Bellamy J; Benoit G
Transplant Proc; 1987 Feb; 19(1 Pt 3):1911-4. PubMed ID: 3547895
[No Abstract] [Full Text] [Related]
15. Contribution of T-cell subset monitoring of renal transplant recipients in the cyclosporine era.
Khanuja PS; Toledo-Pereyra LH; Gordon DA; Bandlien KO; Whitten JI
Transplant Proc; 1989 Feb; 21(1 Pt 2):1852-3. PubMed ID: 2652602
[No Abstract] [Full Text] [Related]
16. Reduction of nephrotoxicity and improvement of immunosuppression by combination of cyclosporine A and azathioprine.
Schareck WD; Hopt UT; Müller GH; Greger B; Risler T; Bockhorn H
Transplant Proc; 1987 Feb; 19(1 Pt 3):1937-9. PubMed ID: 3547898
[No Abstract] [Full Text] [Related]
17. Randomised trial of conversion from cyclosporin to azathioprine at one year after renal transplantation.
Watson MA; Briggs JD; Junor BJ; McMillan MA; Macpherson SG; Murray G; Stewart RM
Transplant Proc; 1989 Feb; 21(1 Pt 2):1583-4. PubMed ID: 2652514
[No Abstract] [Full Text] [Related]
18. Concomitant low-dose cyclosporine and OKT3 therapy for renal transplant rejection.
Hricik DE; Zarconi J; Schulak JA
Transplant Proc; 1989 Feb; 21(1 Pt 2):1755-7. PubMed ID: 2652574
[No Abstract] [Full Text] [Related]
19. Cyclosporin A treatment with successful selective conversion after six months in 70 renal allograft recipients.
Venning MC; Lennard TW; Stevens ME; Proud G; Ward MK; Elliott RW; Taylor RM; Wilkinson R
Transplant Proc; 1989 Feb; 21(1 Pt 2):1633-4. PubMed ID: 2652533
[No Abstract] [Full Text] [Related]
20. Prophylactic use of an antilymphocyte monoclonal antibody following renal transplantation: a randomized controlled trial.
Friend PJ; Calne RY; Hale G; Waldmann H; Evans DB; Rolles K; Thiru S; Gore S
Transplant Proc; 1987 Feb; 19(1 Pt 3):1898-900. PubMed ID: 3079058
[No Abstract] [Full Text] [Related]
[Next] [New Search]